An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity

Carla M. Prado, Isac Lima, Vickie E. Baracos, +7

Cancer Chemotherapy and Pharmacology

Exploratory StudyBody CompositionHealth SciencesPharmacological StudyMedicine +8

Citrate‐Based Tannin‐Bridged Bone Composites for Lumbar Fusion

Jinshan Guo, Xinggui Tian, Denghui Xie, +8

Advanced Functional Materials

EngineeringBiomimetic MaterialsMultifunctional BiomaterialsNatural BoneChemical Composition +15

Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity

Vijaya L. Damaraju, Tara Scriver, Delores Mowles, +4

Clinical Cancer Research

Multitargeted kinase inhibitors imatinib, sorafenib and sunitinib perturb energy metabolism and cause cytotoxicity to cultured C2C12 skeletal muscle derived myotubes

Vijaya L. Damaraju, Michelle Kuzma, Carol E. Cass, +2

Biochemical Pharmacology

Muscle FunctionSkeletal MuscleMedicineReceptor Tyrosine KinaseKinase Inhibitors +7

Transepithelial fluxes of adenosine and 2′-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3

Adam Elwi, Vijaya L. Damaraju, Michelle Kuzma, +5

American Journal of Physiology-Renal Physiology

Cellular PharmacologyApical Hcnt3Cellular PhysiologyRenal FunctionMembrane Transport +20

Characterization of an Anti-MUC1 Monoclonal Antibody with Potential as a Cancer Vaccine

Weimin Qi, Birgit C. Schultes, Dan Liu, +3

Hybridoma and Hybridomics

ImmunologyImmunotherapeuticsImmunotherapyTumor BiologyOncology +19

Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?

Vijaya L. Damaraju, Michelle Kuzma, Delores Mowles, +2

Molecular Cancer Therapeutics

PharmacotherapyImmunotherapeuticsTumor BiologyMolecular PharmacologyMedicinal Chemistry +20

A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer

Michael B. Sawyer, Edith Pituskin, Sambasivarao Damaraju, +17

Clinical Breast Cancer

Breast OncologyEarly-stage Breast CancerMedicineUridine Glucuronosyltransferase 2B7Genetic Epidemiology +9

Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors

Vijaya L. Damaraju, Dwayne Weber, Michelle Kuzma, +2

Journal of Biological Chemistry

Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures

Adam Elwi, Vijaya L. Damaraju, Michelle Kuzma, +4

Cancer Chemotherapy and Pharmacology

Transporter 3UrologyMolecular PhysiologyFludarabine TransportabilityMembrane Transport +11